{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T10:52:09Z","timestamp":1781347929127,"version":"3.54.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,8,19]],"date-time":"2016-08-19T00:00:00Z","timestamp":1471564800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,8,19]],"date-time":"2016-08-19T00:00:00Z","timestamp":1471564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Middle East Respiratory Syndrome coronavirus (MERS-CoV) has repeatedly caused outbreaks in the Arabian Peninsula. To date, no approved medical countermeasures (MCM) are available to combat MERS-CoV infections. Several neutralizing human monoclonal antibodies (mAbs), including m336, a germline-like human mAb, have been chosen as promising MCM for MERS-CoV. However, their clinical development has been hindered by the lack of a robust animal model that recapitulate the morbidity and mortality of human infections. We assessed the prophylactic and therapeutic efficacy of m336 by using well-characterized transgenic mice shown to be highly sensitive to MERS-CoV infection and disease. We found that mice treated with m336 prior to or post lethal MERS-CoV challenging were fully protected, compared to control mice which sufferered from profound weight loss and uniform death within days after infection. Taken together, these results support further development of m336 and other human monoclonal antibodies as potential therapeutics for MERS-CoV infection.<\/jats:p>","DOI":"10.1038\/srep31629","type":"journal-article","created":{"date-parts":[[2016,8,19]],"date-time":"2016-08-19T11:31:39Z","timestamp":1471606299000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Passive Transfer of A Germline-like Neutralizing Human Monoclonal Antibody Protects Transgenic Mice Against Lethal Middle East Respiratory Syndrome Coronavirus Infection"],"prefix":"10.1038","volume":"6","author":[{"given":"Anurodh Shankar","family":"Agrawal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianlei","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinrong","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Garron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Algaissi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bi-Hung","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shibo","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimiter S.","family":"Dimitrov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Te K.","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,19]]},"reference":[{"key":"BFsrep31629_CR1","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.jinf.2012.10.002","volume":"65","author":"JF Chan","year":"2012","unstructured":"Chan, J. F. et al. Is the discovery of the novel human betacoronavirus 2c EMC\/2012 (HCoV-EMC) the beginning of another SARS-like pandemic? J Infect 65, 477\u2013489, doi: 10.1016\/j.jinf.2012.10.002 (2012).","journal-title":"J Infect"},{"key":"BFsrep31629_CR2","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1056\/NEJMoa1306742","volume":"369","author":"A Assiri","year":"2013","unstructured":"Assiri, A. et al. Hospital outbreak of Middle East respiratory syndrome coronavirus. N Engl J Med 369, 407\u2013416, doi: 10.1056\/NEJMoa1306742 (2013).","journal-title":"N Engl J Med"},{"key":"BFsrep31629_CR3","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.3201\/eid1911.131172","volume":"19","author":"ZA Memish","year":"2013","unstructured":"Memish, Z. A. et al. Middle East respiratory syndrome coronavirus in bats, Saudi Arabia. Emerg Infect Dis 19, 1819\u20131823, doi: 10.3201\/eid1911.131172 (2013).","journal-title":"Emerg Infect Dis"},{"key":"BFsrep31629_CR4","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1016\/S0140-6736(13)61887-5","volume":"382","author":"M Cotten","year":"2013","unstructured":"Cotten, M. et al. Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study. Lancet 382, 1993\u20132002, doi: 10.1016\/S0140-6736(13)61887-5 (2013).","journal-title":"Lancet"},{"key":"BFsrep31629_CR5","doi-asserted-by":"publisher","first-page":"8638","DOI":"10.1128\/JVI.01055-13","volume":"87","author":"SK Lau","year":"2013","unstructured":"Lau, S. K. et al. Genetic characterization of Betacoronavirus lineage C viruses in bats reveals marked sequence divergence in the spike protein of pipistrellus bat coronavirus HKU5 in Japanese pipistrelle: implications for the origin of the novel Middle East respiratory syndrome coronavirus. J Virol 87, 8638\u20138650, doi: 10.1128\/JVI.01055-13 (2013).","journal-title":"J Virol"},{"key":"BFsrep31629_CR6","doi-asserted-by":"crossref","unstructured":"van Boheemen, S. et al. Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. MBio 3, doi: 10.1128\/mBio.00473-12 (2012).","DOI":"10.1128\/mBio.00473-12"},{"key":"BFsrep31629_CR7","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1038\/emi.2012.45","volume":"1","author":"PC Woo","year":"2012","unstructured":"Woo, P. C., Lau, S. K., Li, K. S., Tsang, A. K. & Yuen, K. Y. Genetic relatedness of the novel human group C betacoronavirus to Tylonycteris bat coronavirus HKU4 and Pipistrellus bat coronavirus HKU5. Emerg Microbes Infect 1, e35, doi: 10.1038\/emi.2012.45 (2012).","journal-title":"Emerg Microbes Infect"},{"key":"BFsrep31629_CR8","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1128\/JVI.02182-06","volume":"81","author":"PC Woo","year":"2007","unstructured":"Woo, P. C. et al. Comparative analysis of twelve genomes of three novel group 2c and group 2d coronaviruses reveals unique group and subgroup features. J Virol 81, 1574\u20131585, doi: 10.1128\/JVI.02182-06 (2007).","journal-title":"J Virol"},{"key":"BFsrep31629_CR9","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1056\/NEJMoa1401505","volume":"370","author":"EI Azhar","year":"2014","unstructured":"Azhar, E. I. et al. Evidence for camel-to-human transmission of MERS coronavirus. N Engl J Med 370, 2499\u20132505, doi: 10.1056\/NEJMoa1401505 (2014).","journal-title":"N Engl J Med"},{"key":"BFsrep31629_CR10","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/S1473-3099(13)70690-X","volume":"14","author":"BL Haagmans","year":"2014","unstructured":"Haagmans, B. L. et al. Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation. Lancet Infect Dis 14, 140\u2013145, doi: 10.1016\/S1473-3099(13)70690-X (2014).","journal-title":"Lancet Infect Dis"},{"key":"BFsrep31629_CR11","doi-asserted-by":"publisher","first-page":"e00884","DOI":"10.1128\/mBio.00884-14","volume":"5","author":"AN Alagaili","year":"2014","unstructured":"Alagaili, A. N. et al. Middle East respiratory syndrome coronavirus infection in dromedary camels in Saudi Arabia. MBio 5, e00884\u201300814, doi: 10.1128\/mBio.00884-14 (2014).","journal-title":"MBio"},{"key":"BFsrep31629_CR12","doi-asserted-by":"publisher","first-page":"552","DOI":"10.3201\/eid2004.131746","volume":"20","author":"B Meyer","year":"2014","unstructured":"Meyer, B. et al. Antibodies against MERS coronavirus in dromedary camels, United Arab Emirates, 2003 and 2013. Emerg Infect Dis 20, 552\u2013559, doi: 10.3201\/eid2004.131746 (2014).","journal-title":"Emerg Infect Dis"},{"key":"BFsrep31629_CR13","doi-asserted-by":"crossref","unstructured":"Chu, D. K. et al. Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels in Nigeria, 2015. Euro Surveill 20, doi: 10 .2807\/1560-7917.ES.2015.20.49.30086 (2015).","DOI":"10.2807\/1560-7917.ES.2015.20.49.30086"},{"key":"BFsrep31629_CR14","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.3201\/eid2006.140299","volume":"20","author":"DK Chu","year":"2014","unstructured":"Chu, D. K. et al. MERS coronaviruses in dromedary camels, Egypt. Emerg Infect Dis 20, 1049\u20131053, doi: 10.3201\/eid2006.140299 (2014).","journal-title":"Emerg Infect Dis"},{"key":"BFsrep31629_CR15","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1126\/science.aac8608","volume":"351","author":"JS Sabir","year":"2016","unstructured":"Sabir, J. S. et al. Co-circulation of three camel coronavirus species and recombination of MERS-CoVs in Saudi Arabia. Science 351, 81\u201384, doi: 10.1126\/science.aac8608 (2016).","journal-title":"Science"},{"key":"BFsrep31629_CR16","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1056\/NEJMoa1303729","volume":"368","author":"ZA Memish","year":"2013","unstructured":"Memish, Z. A., Zumla, A. I., Al-Hakeem, R. F., Al-Rabeeah, A. A. & Stephens, G. M. Family cluster of Middle East respiratory syndrome coronavirus infections. N Engl J Med 368, 2487\u20132494, doi: 10.1056\/NEJMoa1303729 (2013).","journal-title":"N Engl J Med"},{"key":"BFsrep31629_CR17","doi-asserted-by":"publisher","first-page":"e2015049","DOI":"10.4178\/epih\/e2015049","volume":"37","author":"YS Park","year":"2015","unstructured":"Park, Y. S. et al. The first case of the 2015 Korean Middle East Respiratory Syndrome outbreak. Epidemiol Health 37, e2015049, doi: 10.4178\/epih\/e2015049 (2015).","journal-title":"Epidemiol Health"},{"key":"BFsrep31629_CR18","doi-asserted-by":"crossref","unstructured":"Korea Centers for Disease, C. & Prevention. Middle East Respiratory Syndrome Coronavirus Outbreak in the Republic of Korea, 2015. Osong Public Health Res Perspect 6, 269\u2013278, doi: 10.1016\/j.phrp.2015.08.006 (2015).","DOI":"10.1016\/j.phrp.2015.08.006"},{"key":"BFsrep31629_CR19","doi-asserted-by":"publisher","first-page":"755-","DOI":"10.1093\/cid\/civ1020","volume":"62","author":"SY Bin","year":"2016","unstructured":"Bin, S. Y. et al. Environmental Contamination and Viral Shedding in MERS Patients During MERS-CoV Outbreak in South Korea. Clin Infect Dis 62, 755- 760, doi: 10.1093\/cid\/civ1020 (2016).","journal-title":"Clin Infect Dis"},{"key":"BFsrep31629_CR20","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nature12005","volume":"495","author":"VS Raj","year":"2013","unstructured":"Raj, V. S. et al. Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature 495, 251\u2013254, doi: 10.1038\/nature12005 (2013).","journal-title":"Nature"},{"key":"BFsrep31629_CR21","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nature12328","volume":"500","author":"G Lu","year":"2013","unstructured":"Lu, G. et al. Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26. Nature 500, 227\u2013231, doi: 10.1038\/nature12328 (2013).","journal-title":"Nature"},{"key":"BFsrep31629_CR22","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1038\/cr.2013.92","volume":"23","author":"N Wang","year":"2013","unstructured":"Wang, N. et al. Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4. Cell Res 23, 986\u2013993, doi: 10.1038\/cr.2013.92 (2013).","journal-title":"Cell Res"},{"key":"BFsrep31629_CR23","doi-asserted-by":"publisher","first-page":"7796","DOI":"10.1128\/JVI.00912-14","volume":"88","author":"T Ying","year":"2014","unstructured":"Ying, T. et al. Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies. J Virol 88, 7796\u20137805, doi: 10.1128\/JVI.00912-14 (2014).","journal-title":"J Virol"},{"key":"BFsrep31629_CR24","doi-asserted-by":"publisher","first-page":"234ra259","DOI":"10.1126\/scitranslmed.3008140","volume":"6","author":"L Jiang","year":"2014","unstructured":"Jiang, L. et al. Potent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein. Sci Transl Med 6, 234ra259, doi: 10.1126\/scitranslmed.3008140 (2014).","journal-title":"Sci Transl Med"},{"key":"BFsrep31629_CR25","doi-asserted-by":"publisher","first-page":"7045","DOI":"10.1128\/JVI.00433-14","volume":"88","author":"L Du","year":"2014","unstructured":"Du, L. et al. A conformation-dependent neutralizing monoclonal antibody specifically targeting receptor-binding domain in Middle East respiratory syndrome coronavirus spike protein. J Virol 88, 7045\u20137053, doi: 10.1128\/JVI.00433-14 (2014).","journal-title":"J Virol"},{"key":"BFsrep31629_CR26","doi-asserted-by":"publisher","first-page":"E2018","DOI":"10.1073\/pnas.1402074111","volume":"111","author":"XC Tang","year":"2014","unstructured":"Tang, X. C. et al. Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution. Proc Natl Acad Sci USA 111, E2018\u20132026, doi: 10.1073\/pnas.1402074111 (2014).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep31629_CR27","doi-asserted-by":"publisher","first-page":"10473","DOI":"10.1073\/pnas.1510199112","volume":"112","author":"D Corti","year":"2015","unstructured":"Corti, D. et al. Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus. Proc Natl Acad Sci USA 112, 10473\u201310478, doi: 10.1073\/pnas.1510199112 (2015).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep31629_CR28","doi-asserted-by":"publisher","first-page":"8738","DOI":"10.1073\/pnas.1510830112","volume":"112","author":"KE Pascal","year":"2015","unstructured":"Pascal, K. E. et al. Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection. Proc Natl Acad Sci USA 112, 8738\u20138743, doi: 10.1073\/pnas.1510830112 (2015).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep31629_CR29","doi-asserted-by":"publisher","first-page":"8223","DOI":"10.1038\/ncomms9223","volume":"6","author":"T Ying","year":"2015","unstructured":"Ying, T. et al. Junctional and allele-specific residues are critical for MERS-CoV neutralization by an exceptionally potent germline-like antibody. Nat Commun 6, 8223, doi: 10.1038\/ncomms9223 (2015).","journal-title":"Nat Commun"},{"key":"BFsrep31629_CR30","doi-asserted-by":"publisher","first-page":"e1004250","DOI":"10.1371\/journal.ppat.1004250","volume":"10","author":"D Falzarano","year":"2014","unstructured":"Falzarano, D. et al. Infection with MERS-CoV causes lethal pneumonia in the common marmoset. PLoS Pathog 10, e1004250, doi: 10.1371\/journal.ppat.1004250 (2014).","journal-title":"PLoS Pathog"},{"key":"BFsrep31629_CR31","doi-asserted-by":"publisher","first-page":"6131","DOI":"10.1128\/JVI.00661-15","volume":"89","author":"BL Haagmans","year":"2015","unstructured":"Haagmans, B. L. et al. Asymptomatic Middle East respiratory syndrome coronavirus infection in rabbits. J Virol 89, 6131\u20136135, doi: 10.1128\/JVI.00661-15 (2015).","journal-title":"J Virol"},{"key":"BFsrep31629_CR32","doi-asserted-by":"crossref","unstructured":"Houser, K. V. et al. Prophylaxis with a MERS-CoV-specific human monoclonal antibody protects rabbits from MERS-CoV infection. J Infect Dis, doi: 10.1093\/infdis\/jiw080 (2016).","DOI":"10.1093\/infdis\/jiw080"},{"key":"BFsrep31629_CR33","doi-asserted-by":"publisher","first-page":"4970","DOI":"10.1073\/pnas.1323279111","volume":"111","author":"J Zhao","year":"2014","unstructured":"Zhao, J. et al. Rapid generation of a mouse model for Middle East respiratory syndrome. Proc Natl Acad Sci USA 111, 4970\u20134975, doi: 10.1073\/pnas.1323279111 (2014).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep31629_CR34","doi-asserted-by":"publisher","first-page":"3659","DOI":"10.1128\/JVI.03427-14","volume":"89","author":"AS Agrawal","year":"2015","unstructured":"Agrawal, A. S. et al. Generation of a transgenic mouse model of Middle East respiratory syndrome coronavirus infection and disease. J Virol 89, 3659\u20133670, doi: 10.1128\/JVI.03427-14 (2015).","journal-title":"J Virol"},{"key":"BFsrep31629_CR35","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.antiviral.2015.07.005","volume":"122","author":"N van Doremalen","year":"2015","unstructured":"van Doremalen, N. & Munster, V. J. Animal models of Middle East respiratory syndrome coronavirus infection. Antiviral Res 122, 28\u201338, doi: 10.1016\/j.antiviral.2015.07.005 (2015).","journal-title":"Antiviral Res"},{"key":"BFsrep31629_CR36","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1038\/cr.2015.113","volume":"25","author":"Y Li","year":"2015","unstructured":"Li, Y. et al. A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein. Cell Res 25, 1237\u20131249, doi: 10.1038\/cr.2015.113 (2015).","journal-title":"Cell Res"},{"key":"BFsrep31629_CR37","doi-asserted-by":"publisher","first-page":"326ra321","DOI":"10.1126\/scitranslmed.aaf1061","volume":"8","author":"T Luke","year":"2016","unstructured":"Luke, T. et al. Human polyclonal immunoglobulin G from transchromosomic bovines inhibits MERS-CoV in vivo . Sci Transl Med 8, 326ra321, doi: 10.1126\/scitranslmed.aaf1061 (2016).","journal-title":"Sci Transl Med"},{"key":"BFsrep31629_CR38","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1128\/JVI.02009-15","volume":"90","author":"X Tao","year":"2015","unstructured":"Tao, X. et al. Characterization and Demonstration of the Value of a Lethal Mouse Model of Middle East Respiratory Syndrome Coronavirus Infection and Disease. J Virol 90, 57\u201367, doi: 10.1128\/JVI.02009-15 (2015).","journal-title":"J Virol"},{"key":"BFsrep31629_CR39","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1038\/nbt1363","volume":"25","author":"WA Marasco","year":"2007","unstructured":"Marasco, W. A. & Sui, J. The growth and potential of human antiviral monoclonal antibody therapeutics. Nat Biotechnol 25, 1421\u20131434, doi: 10.1038\/nbt1363 (2007).","journal-title":"Nat Biotechnol"},{"key":"BFsrep31629_CR40","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nrmicr","volume":"7","author":"L Du","year":"2009","unstructured":"Du, L. et al. The spike protein of SARS-CoV\u2013a target for vaccine and therapeutic development. Nat Rev Microbiol 7, 226\u2013236, doi: 10.1038\/nrmicro2090 (2009).","journal-title":"Nat Rev Microbiol"},{"key":"BFsrep31629_CR41","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1128\/CMR.13.4.602","volume":"13","author":"MA Keller","year":"2000","unstructured":"Keller, M. A. & Stiehm, E. R. Passive immunity in prevention and treatment of infectious diseases. Clin Microbiol Rev 13, 602\u2013614 (2000).","journal-title":"Clin Microbiol Rev"},{"key":"BFsrep31629_CR42","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1086\/600381","volume":"200","author":"T Couderc","year":"2009","unstructured":"Couderc, T. et al. Prophylaxis and therapy for Chikungunya virus infection. J Infect Dis 200, 516\u2013523, doi: 10.1086\/600381 (2009).","journal-title":"J Infect Dis"},{"key":"BFsrep31629_CR43","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s40409-015-0003-1","volume":"21","author":"JP Chippaux","year":"2015","unstructured":"Chippaux, J. P., Boyer, L. V. & Alagon, A. Post-exposure treatment of Ebola virus using passive immunotherapy: proposal for a new strategy. J Venom Anim Toxins Incl Trop Dis 21, 3, doi: 10.1186\/s40409-015-0003-1 (2015).","journal-title":"J Venom Anim Toxins Incl Trop Dis"},{"key":"BFsrep31629_CR44","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1038\/ncomms4067","volume":"5","author":"L Lu","year":"2014","unstructured":"Lu, L. et al. Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor. Nat Commun 5, 3067, doi: 10.1038\/ncomms4067 (2014).","journal-title":"Nat Commun"},{"key":"BFsrep31629_CR45","doi-asserted-by":"publisher","first-page":"11654","DOI":"10.1128\/JVI.01815-15","volume":"89","author":"AH Malczyk","year":"2015","unstructured":"Malczyk, A. H. et al. A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform. J Virol 89, 11654\u201311667, doi: 10.1128\/JVI.01815-15 (2015).","journal-title":"J Virol"},{"key":"BFsrep31629_CR46","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1128\/JVI.01702-06","volume":"81","author":"CT Tseng","year":"2007","unstructured":"Tseng, C. T. et al. Severe acute respiratory syndrome coronavirus infection of mice transgenic for the human Angiotensin-converting enzyme 2 virus receptor. J Virol 81, 1162\u20131173, doi: 10.1128\/JVI.01702-06 (2007).","journal-title":"J Virol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep31629.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep31629","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep31629.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T05:20:14Z","timestamp":1672896014000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep31629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,19]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,8,30]]}},"alternative-id":["BFsrep31629"],"URL":"https:\/\/doi.org\/10.1038\/srep31629","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,19]]},"assertion":[{"value":"13 May 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"31629"}}